FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical industry, particularly to an agent for preventing or treating viral infection caused by herpes simplex virus (HSV). Extract from stem (trunk with bark), bark, branches and trunk bark plant Ficus arnottiana, resulting in a certain way, for prevention or treatment of a viral infection caused by herpes simplex virus (HSV). Composition comprising a therapeutically effective amount of an extract of the trunk (trunk bark), bark, twigs or stem bark plants Ficus arnottiana and a pharmaceutically acceptable carrier, for prevention or treatment of a viral infection caused by herpes simplex virus (HSV). A method for preparing the composition. Method of treating viral infection in a subject caused by herpes simplex virus (HSV), comprising a step in which a subject is administered said composition. Use of a composition for prevention or treatment of a viral infection caused by herpes simplex virus (HSV). Application isolated extract and a pharmaceutically acceptable carrier to produce a medicament for prevention or treatment of a viral infection caused by herpes simplex virus (HSV).
EFFECT: agents described above are effective for preventing or treating a viral infection caused by herpes simplex virus (HSV).
24 cl, 10 dwg, 4 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF FIREWEED LEAVES EPILOBIUM ANGUSTIFOLIUM L., WHICH EXHIBITS INHIBITORY ACTIVITY AGAINST SARS-CoV-2 CORONAVIRUS AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO | 2022 |
|
RU2788172C1 |
| USE OF ALCOHOLIC EXTRACT OF AERIAL PARTS OF MARAL ROOT RHAPONTICUM CARTHAMOIDES AS AGENT, INHIBITING ACTIVITY OF CORONAVIRUS SARS-CoV-2 AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2825393C1 |
| ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
| ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
| 4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 |
|
RU2573977C9 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF BASIDIOMYCETE Coprinus comatus | 2015 |
|
RU2584751C1 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF XYLOTROPHIC BASIDIOMYCETES Bjerkandera adusta | 2015 |
|
RU2580296C1 |
| SARS-CoV-2 CORONAVIRUS REPLICATION INHIBITOR BASED ON HUMIC SUBSTANCES | 2020 |
|
RU2752872C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HERBAL EXTRACTS FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS | 2009 |
|
RU2401121C1 |
| MELANINE ANTIVIRAL AGENT | 2011 |
|
RU2480227C2 |
